Cargando…
Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT
The current National Comprehensive Cancer Network (NCCN) Guidelines consider the role of 2-deoxy-2-(18)F-fluoro-d-glucose positron emission tomography/computer tomography (FDG PET/CT) in the evaluation of cholangiocarcinoma (CCA) as "uncertain," and have recommended contrast enhanced compu...
Autores principales: | Elias, Youssef, Mariano, Aladin T., Lu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020788/ https://www.ncbi.nlm.nih.gov/pubmed/27651736 http://dx.doi.org/10.4103/1450-1147.167605 |
Ejemplares similares
-
Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019) -
(18)F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
por: Gajendra, Smeeta, et al.
Publicado: (2016) -
Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022) -
Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
por: Adams, Hugo J. A., et al.
Publicado: (2016) -
Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI
por: Papamichail, Dimitris, et al.
Publicado: (2019)